Nectar Lifescience Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹0.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 100.00 per cent from ₹0.71 crore. This corresponds to a year-on-year *(YoY) decline of 100.00 per cent.
Operating Profit
Operating Profit stands at ₹-55.28 crore, reflecting a quarter-on-quarter *(QoQ) increase of 68.55 per cent from ₹-175.76 crore. This corresponds to a year-on-year *(YoY) decline of 1,38,100.00 per cent.
PBDT
PBDT stands at ₹3.31 crore, reflecting a quarter-on-quarter *(QoQ) increase of 101.88 per cent from ₹-175.74 crore. This corresponds to a year-on-year *(YoY) decline of 58.78 per cent.
Profit Before Tax
Profit Before Tax stands at ₹3.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 101.85 per cent from ₹-175.85 crore. This corresponds to a year-on-year *(YoY) decline of 59.17 per cent.
Net Profit
Net Profit stands at ₹14.27 crore, reflecting a quarter-on-quarter *(QoQ) increase of 108.11 per cent from ₹-176.01 crore. This represents a 82.02 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Nectar Lifescience Ltd Earnings
- YOY
- QOQ
Nectar Lifescience Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Nectar Lifescience Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Nectar Lifescience Ltd Financial Reports
Nectar Lifescience Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Nectar Lifesci. | 0.72% | 4.05% | 35.12% | -6.26% | -20.73% | -42.92% |
| Syschem (India) | 1.73% | 0.37% | 25.56% | 10.69% | -4.47% | 27.97% |
| Ambalal Sarabhai | -2.09% | 1.70% | 33.13% | 17.15% | 0.37% | -11.38% |
| Gennex Lab. | -2.03% | -1.65% | 41.80% | -17.80% | -38.43% | -23.35% |
| Lyka Labs | 2.23% | 1.50% | 37.22% | -14.06% | -35.04% | -44.64% |
| BDH Industries | 3.39% | -0.43% | 6.02% | -0.56% | -12.01% | 39.87% |
| Oxygenta Pharma | 0.27% | 2.19% | 13.99% | -12.06% | -10.73% | -33.86% |
Company Info
Company Information
Chairman & Managing Director : Sanjiv Goyal
Independent Non Exe. Director : Rupinder Tewari
Independent Non Exe. Director : Kuldip Kumar Bhasin
Independent Non Exe. Director : Indu Pal Kaur
Executive Director : Surulichamy Senthilkumar
Company Sec. & Compli. Officer : Sanjaymohan Singh Rawat
WTD & Director (Finance) : Sushil Kapoor